Author/Authors :
Seyyedpour، Seyyed Hosein نويسنده Deputy of Health, Mazandaran University of Medical Sciences, Sari, IR Iran , , Afshar، Parvaneh نويسنده Referral Laboratory, Mazandaran University of Medical Sciences, Sari, IR Iran , , Barzegarnejad، Ayoub نويسنده Department of Urology, Medical School, Mazandaran University of Medical Sciences, Sari, IR Iran , , Kalhori، Shamsi نويسنده Mazandaran University of Medical Sciences, Sari, IR Iran , , Agah، Reza نويسنده Deputy of Treatment, Mazandaran University of Medical Sciences, Sari, IR Iran ,
Abstract :
Toxoplasma gondii has worldwide distribution and is one of the most prevalent infectious agents in humans. The aim of this study was to determine the prevalence of anti-Toxoplasma gondii antibodies in hemodialysis patients with chronic kidney disease (CKD) in the hemodialysis unit of Fatemeh Zahra hospital at the Mazandaran University of Medical Sciences in Sari, Iran. Seventy-three patients with CKD and 145 healthy volunteers were assessed for anti-Toxoplasma gondii (IgG, IgM, and IgA) antibodies using a conventional ELISA technique. The anti-Toxoplasma gondii IgG antibody was detected in 80.8% of the cases in the patient group, while 31.5% of the cases in the CKD patient group and 31.8% in the control group were found to be positive for the anti-Toxoplasma gondii IgA antibody. All the patients in the CKD group were negative for the anti-Toxoplasma gondii IgM antibody, although 2.76% of the healthy volunteers were found to be positive. The present study suggests that there was no significant difference between the hemodialysis patient group and the healthy volunteers. The epidemiological data collected in this study could serve as a reference for future studies and may be useful in developing preventive and educational strategies, and consequently reducing healthcare expenditure.
